Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ronald G. Gelbman currently holds 48,384 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald G. Gelbman has been a net seller of HAE stock. They have purchased $199.9K and sold $7.7M worth of shares.
Ronald G. Gelbman's most recent insider trade was on Nov 11, 2019, when they sold 16,926 shares at $118.26 per share.
Ronald G. Gelbman serves as Executive at HAEMONETICS CORP (HAE). They have executed 74 insider transactions totaling $7.9M over their tenure at the company.
Ronald G. Gelbman holds the position of Executive at HAEMONETICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Ronald G. Gelbman has shown a selling trading pattern, with $199.9K in total purchases and $7.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ronald G. Gelbman was on Nov 11, 2019, when they sold $2.0M worth of HAE shares. This transaction involved 16,926 shares at $118.26 per share.
Ronald G. Gelbman currently owns 48,384 shares of HAEMONETICS CORP (HAE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ronald G. Gelbman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ronald G. Gelbman has 74 Form 4 filings on record as an insider at HAEMONETICS CORP.
Set alerts for Ronald G. Gelbman and 40,000+ other insiders.